Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
The purpose of the study is to examine the toxicity profile, maximum tolerated dose (MTD), and pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection.
Neoplasms
DRUG: Mitoxantrone Hydrochloride Liposome|DRUG: Mitoxantrone
To determination the maximal tolerance dose and dose-limiting toxicity of Mitoxantrone Hydrochloride Liposome, 3 Weeks
The trial of the dose escalation method is from the minimum dose until the maximum tolerated dose and every 3 patient is a dose group.